生物制剂引入以来银屑病发作住院率趋势:2005年至2015年法国时间序列研究
该研究基于法国九家医院2005至2015年全国住院数据库的3572例银屑病发作住院,分析生物制剂引入前后住院率变化。生物制剂引入未伴随银屑病发作住院数下降,反而观察到非显著性增加(每季度每万张床13例住院);在两中心分析中,生物制剂引入与仅接受外用治疗患者及首次银屑病发作患者的住院显著增加相关。
要点
- 生物制剂引入未伴随银屑病发作住院数下降,反而呈非显著性增加。
- 两中心分析中,仅外用治疗患者住院显著增加(每年每万张床520例)。
- 两中心分析中,首次银屑病发作患者住院亦显著增加。
核心结论
- 2005至2015年间银屑病发作住院数呈增加趋势。
- 生物制剂引入未伴随银屑病发作住院数下降,反而观察到非显著性增加。
- 作者认为额外治疗选择的可及性可能增加了患者需求或拓宽了临床实践中的适应症。
研究设计与样本
- 基于法国九家医院2005至2015年全国住院数据库的住院数据分析。
- 共纳入3572例银屑病发作住院。
- 在两中心还分析了患者个体电子病历数据。
主要发现
- 生物制剂引入未伴随银屑病发作住院数下降,反而观察到非显著性增加(每季度每万张床13例银屑病发作住院)。
- 两中心研究中,生物制剂引入与仅接受外用治疗患者的住院显著增加相关(每年每万张床520例住院)。
- 两中心研究中,生物制剂引入与首次银屑病发作患者的住院显著增加相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the late 2000s, the introduction of biologics transformed the prognosis for patients with moderate-to-severe psoriasis. We hypothesized that treatment with biologics may associate with a reduction in the hospitalization rate for psoriasis flares. OBJECTIVE: To analyse changes over time in the hospitalization rate for psoriasis flares. METHODS: We included inpatient stays in any of nine French hospitals between 2005 and 2015 for a psoriasis flare, as documented in the national inpatient database. In two centres, we also analysed data from the individual patients' electronic medical records. RESULTS: A total of 3572 stays were included. The introduction of biologics was not associated with a decrease in the number of hospitalizations for a psoriasis flare; on the contrary, we observed a non-significant increase in the number of hospitalizations (13 hospitalizations for psoriasis flares per quarter per 10 000 beds). In the two-centre study, the introduction of biologics was associated with a significant increase in the hospitalization of patients receiving topical treatments only (520 hospitalizations per year per 10 000 beds) and those with a first psoriasis flare. CONCLUSION: The number of hospitalizations for a psoriasis flare tended to increase between 2005 and 2015. The availability of additional treatment options might have increased patient demand and/or broadened the indications in clinical practice.
引用
- Polivka L, Oubaya N, Bachelez H, et al. Trends in hospitalization rates for psoriasis flares since the introduction of biologics: a time series in France between 2005 and 2015. J Eur Acad Dermatol Venereol. 2018. PMID: 29729123. doi:10.1111/jdv.15044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。